The prothrombin G20210A mutation is the second most common inherited predisposition to hypercoagulability. Heterozygous prothrombin G20210A mutation is associated with a 2 to 6 fold increased lifetime relative risk of VTE. This risk is further increased in combination with pregnancy and OCP use.
Duly filled Genomics Clinical Information Requisition Form is mandatory.
Download the free health test app from Dr. B. Lal Clinical Laboratory. Find all the healthcare information and needs you require in just one place. You can schedule home collection, see reports, save medical history, search for more than 1800 tests, and more with just one app. Available both on iOS and Android. Simplify healthcare, download the Dr. B. Lal Clinical Lab App.